Cargando…
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752190/ https://www.ncbi.nlm.nih.gov/pubmed/35031489 http://dx.doi.org/10.1016/j.cmi.2021.12.014 |
_version_ | 1784631834786660352 |
---|---|
author | Trøseid, Marius Diallo, Alpha Hites, Maya Røttingen, John-Arne Yazdanpanah, Yazdan |
author_facet | Trøseid, Marius Diallo, Alpha Hites, Maya Røttingen, John-Arne Yazdanpanah, Yazdan |
author_sort | Trøseid, Marius |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8752190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87521902022-01-12 Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response Trøseid, Marius Diallo, Alpha Hites, Maya Røttingen, John-Arne Yazdanpanah, Yazdan Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-05 2022-01-12 /pmc/articles/PMC8752190/ /pubmed/35031489 http://dx.doi.org/10.1016/j.cmi.2021.12.014 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Trøseid, Marius Diallo, Alpha Hites, Maya Røttingen, John-Arne Yazdanpanah, Yazdan Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title_full | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title_fullStr | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title_full_unstemmed | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title_short | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response |
title_sort | accelerating clinical trial implementation in the context of the covid-19 pandemic: author's response |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752190/ https://www.ncbi.nlm.nih.gov/pubmed/35031489 http://dx.doi.org/10.1016/j.cmi.2021.12.014 |
work_keys_str_mv | AT trøseidmarius acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse AT dialloalpha acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse AT hitesmaya acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse AT røttingenjohnarne acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse AT yazdanpanahyazdan acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse |